RH40-Driven Competitive Hydrophobic Interactions Break the VA64 Cage to Rescue Probucol Spring-Parachute Supersaturation

Authors:

Abstract
Copovidone (Kollidon® VA64) is a widely utilized excipient in binary solid dispersions (SDs) to maintain drug supersaturation and enhance oral absorption. However, for poorly water-soluble drugs like probucol (PB), strong drug-polymer interactions can act as a "cage" that severely restricts drug release. Consequently, ternary polymer-additive-drug SDs have emerged as an effective strategy to overcome single-polymer limitations. This study investigates how introducing the amphiphilic additive Kolliphor® RH40 into VA64-PB SDs influences solid-state formation and in vitro release behavior. By monitoring glass transition temperatures across various drug loadings, alongside FTIR and Raman spectroscopy, intermolecular interactions were comprehensively evaluated. Results confirmed that a strong hydrogen bond forms between the carbonyl group of VA64's pyrrolidone ring and the phenolic hydroxyl group of PB in binary systems. Crucially, amphiphilic nature of RH40 disrupts this VA64-PB interaction, actively competing for PB through hydrophobic and hydrogen-bonded interactions. In vitro release studies and gel permeation chromatography (GPC) revealed that the binary VA64-PB system exhibits incongruent release at low drug loadings, characterized by rapid polymer dissolution and in situ drug crystallization (Form I). Conversely, the ternary VA64-RH40-PB system demonstrates rapid, synchronous dissolution. The resulting RH40-PB micelles, which display a trend toward Form II recrystallization, undergo phase separation from VA64. Furthermore, molecular dynamics (MD) simulations and mIGH analysis elucidated that RH40 competes for PB adjacent to VA64 via van der Waals forces and hydrogen bonding. This study underscores the pivotal role of non-ionic amphiphilic additives in modulating polymer-drug interactions within complex systems, providing a valuable reference for rational excipient compatibility and optimizing release profiles in amorphous formulations.